"There were no benefits of a reverse merger not offset by the drawbacks."

– Fran Stoller, partner with law firm Loeb & Loeb LLP, which advised Coronado Biosciences Inc. on filing a Form-10 rather than pursuing a reverse merger

"I realize it's absurd to talk about 10Xs or even 5Xs these days."

– Roger Longman, CEO of Real Endpoints LLC

"To get competition [in drug pricing], you have to pick winners or losers."

– Jonathan Blum, Medicare deputy administrator and director at CMS, speaking at a hearing of the Senate Special Committee on Aging

"It's the dream that the next experiment probably won't work, but it might."

– Jim Greenwood, BIO president and CEO, on what keeps bio pushing against the odds